Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma
Conditions
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: fenretinide lipid matrix
Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators